Meridian Bioscience (VIVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2017 | 09-2016 | 09-2015 | 09-2014 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 57,072 | 47,226 | 49,973 | 43,047 | 44,282 |
| Receivables | 29,106 | 27,102 | 26,254 | 23,232 | 26,183 |
| Inventories | 41,493 | 45,057 | 35,817 | 35,495 | 34,835 |
| Income taxes - deferred | N/A | N/A | N/A | 3,916 | 4,145 |
| TOTAL | $133,875 | $126,791 | $119,422 | $112,748 | $114,088 |
| Non-Current Assets | |||||
| PPE Net | 30,510 | 30,450 | 27,492 | 27,610 | 26,091 |
| Intangibles | 81,630 | 91,837 | 28,280 | 31,006 | 31,172 |
| Other Non-Current Assets | 3,762 | 2,950 | 8,088 | 5,565 | 5,397 |
| TOTAL | $115,902 | $125,237 | $63,860 | $64,181 | $62,660 |
| Total Assets | $249,777 | $252,028 | $183,282 | $176,929 | $176,748 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,500 | 3,750 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 7,719 | 7,627 | 6,646 | 4,966 | 5,592 |
| Accrued Expenses | 4,536 | 7,106 | 5,132 | 4,761 | 9,847 |
| Other current liabilities | 2,095 | N/A | N/A | N/A | N/A |
| TOTAL | $22,887 | $22,571 | $15,251 | $13,735 | $19,617 |
| Non-Current Liabilities | |||||
| Long Term Debt | 50,147 | 54,610 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 2,703 | 5,417 | 2,158 | 2,165 | 2,086 |
| TOTAL | $57,305 | $62,985 | $2,158 | $2,165 | $2,086 |
| Total Liabilities | $80,192 | $85,556 | $17,409 | $15,900 | $21,703 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,217 | 42,108 | 41,846 | 41,645 | 41,518 |
| Retained earnings | 46,923 | 49,632 | 51,052 | 48,869 | 46,888 |
| Other shareholders' equity | -2,946 | -5,516 | -2,330 | 309 | 745 |
| TOTAL | $169,585 | $166,472 | $165,873 | $161,029 | $155,045 |
| Total Liabilities And Equity | $249,777 | $252,028 | $183,282 | $176,929 | $176,748 |